Seoul:South Korean biosimilar company Samsung Epis Holdings has announced a net profit of 96.3 billion won (US$71.9 million) for the third quarter.
According to Yonhap News Agency, the company, which is part of the Samsung Group, disclosed these figures in a regulatory filing. For the July-September period, Samsung Epis Holdings reported an operating profit of 105.1 billion won.
The biotech firm's revenue for the third quarter was reported at 441.9 billion won, reflecting its financial performance during this period.